TRU-Cut Biopsy in Tumor cHaracterisation
Recruiting
Observational Study
Tumor
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Female
- Study type
- Observational
- Participants needed
- 250 (estimated)
- Sponsor
- General University Hospital, Prague · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Tru-cut biopsy (TCB) is a minimally invasive method to get an adequate sample from the lesion in order to tailor the appropriate management avoiding unnecessary surgery. The aim of our trial is to evaluate the adequacy, accuracy and safety of the method related to the final histology as reference standard.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria: Presence of a pelvic/abdominal lesion with suspicion of malignancy:
1. new diagnosis of a presumed gynecologic tumor
2. suspicious recurrence or progression of a known gynecologic malignancy
3. pelvic/abdominal spread or recurrence of a non-gynecologic tumor (primary tumor or me…
Contacts